Transurethral 160-W straight beam green laser vaporesection of the prostate: initial experience after 180 procedures by unknown
Li et al. SpringerPlus  (2016) 5:308 
DOI 10.1186/s40064-016-1776-6
RESEARCH
Transurethral 160-W straight beam 
green laser vaporesection of the prostate:  
initial experience after 180 procedures
Lianjun Li†, Bo Hu†, Muwen Wang, Peng Sun and Xunbo Jin*
Abstract 
Although the photoselective vaporization of the prostate has been considered one of the most promising alternatives 
for treatment of benign prostatic hyperplasia (BPH), published clinical data with the surgical technology of straight 
beam lithium triborate laser (LBO) is still lacking. To evaluate the technical improvement and initial experience of the 
160-W straight beam LBO laser photoselective vaporesection of the prostate (PVRP) for the surgical treatment of BPH. 
From September 2012 to September 2014, including a 12-month follow-up, a prospective randomized study was 
performed. 180 patients undergoing PVRP were included in the study. All patients were preoperatively assessed by 
International Prostate Symptom Score (IPSS), maximum flow rate (Qmax), post-void residual urine (PVR), prostate-spe-
cific antigen level, and prostate volume measurement. Perioperative parameters and complications were recorded. 
Patients were reassessed at 1, 3, 6 and 12 months postoperatively. PVRP resulted in a significant improvement of 
IPSS, Qmax, and PVR. Mean operative time was 48.3 ± 14.4 min. A significant improvement for PVRP was achieved 
regarding the catheter indwelling and hospital stay time. No severe perioperative complications were recorded. No 
requiring blood transfusion in all patients. Capsule perforation was observed in four patients in the group. There were 
four patients experienced bladder neck contracture and another four patients were diagnosed urethral stricture, all 
of whom were treated well by dilatation finally without reoperation. 160-W straight beam LBO laser PVRP appears to 
be a feasible and safe alternative for symptomatic BPH with decreased length of catheter indwelling and hospital stay 
time postoperatively.
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Background
Reza Malek first reported photoselective vaporization of 
the prostate (PVP) of benign prostatic hyperplasia (BPH) 
using the potassium-titanyl-phosphate (KTP) 80-W sys-
tem in 1996 (Malek et  al. 2005). Since then the surgical 
technique has been a rapid development. The 120-W 
green laser device used to treat BPH was first reported 
in 2006 (Hermanns et  al. 2011; Ben-Zvi et  al. 2013). 
The application report of 180-W XPS system indicated 
that the power increased substantially (Bachmann et  al. 
2012, 2014). Furthermore, Yong-Guang Gong reported 
the 120-W front-fire lithium triborate laser (LBO) pho-
toselective vaporesection of the prostate (PVRP) for 
the surgical treatment of BPH (Gong et al. 2014). These 
improvement greatly enhance the operation efficiency 
and therefore reduce the risk of surgery. Increasing study 
over the past 10 years indicates that PVP with green laser 
is equally effective as trans-urethral resection of prostate 
(TURP) in BPH treatment (Chen et al. 2012; Emara and 
Barber 2014; Teng et al. 2013). Above all, the green laser 
vaporization surgery can strongly challenge the status of 
TURP as the gold standard in surgical treatment of BPH.
There have been reported that the technologies of PVP 
has had specific benefits over TURP in terms of shorter 
duration for catheterization and hospital stay (Guo et al. 
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2015; Chen et  al. 2012). Despite these advantages, the 
shortcomings of conventional PVP are obvious, even for 
experienced surgeons of green laser operations. Com-
pared with TURP, the main problems of traditional PVP 
surgery include that wash water circulation is poor which 
cause unclear visualization, speed of vaporization is too 
slow, the apex of prostate is more likely to have residual 
gland, and bleeding during the surgery is difficult to be 
stopped, some of which problems have been improved by 
using of 180 W XPS system (Schwartz et al. 2011; West 
and Woo 2015).
Based on these reasons, we use trans-urethral plasma 
kinetic resection instrument to perform green laser sur-
gery in order to improve the rinse water to achieve a clear 
vision. Furthermore, we proposed the method of photo-
selective retrograde stripping-vaporization of the pros-
tate (PRSVP), which is a new form of PVRP. Currently, 
there is still little experience reported on the new straight 
beam LBO laser. We summarize the data from 180 
patients treated from 2012 to 2014, including a 12-month 
follow-up, so that to evaluate the safety and efficacy of 
PRSVP using the 160-W straight beam LBO laser.
Methods
This prospective study was performed between Sep-
tember 2012 and September 2014 in Provincial Hos-
pital Affiliated to Shandong University. A total of 180 
patients suffering from BPO due to BPH and failed pre-
vious medical therapy were included in this study. The 
patients were treated with the 160  W straight beam 
LBO laser PRSVP by one experienced urologist in our 
department. Written consent was obtained from all par-
ticipants and the protocol was approved by the ethics 
committee.
Inclusion criteria were patients with lower urinary tract 
symptoms due to BPH and indications for the surgical 
treatment. Men with a history of prostate cancer, urethral 
stricture, bladder neck sclerosis, and neurogenic blad-
der were excluded from analysis. Anticoagulant therapy 
for patients in the group was not discontinued before 
surgery.
The perioperative outcomes included operating time, 
laser working time, applied energy, length of catheteri-
zation and hospital stay. Serum sodium and hemoglobin 
level were also evaluated before and after the operation. 
The prostate size was measured by transrectal ultra-
sonography (TRUS). All patients were reevaluated at 1, 
3, 6, and 12  months postoperatively and adverse events 
were also assessed. Functional evaluation such as Inter-
national Prostate Symptom Score (IPSS), maximum flow 
rate (Qmax), post-void residual urine (PVR), prostate-
specific antigen (PSA) level, and prostate volume were 
measured at baseline and each point.
Statistical analysis was performed using the SPSS 11.5 
software package. Data was expressed as mean ±  stand-
ard deviation. Ordinal data was analyzed using the Stu-
dent’s t test when comparisons were made and p value of 
less than 0.05 was considered to be statistically significant.
Surgical technique
Related surgical devices for preoperative preparation 
were listed in Table 1. Before the start of surgery, we need 
to use the ureteral stent for directing the laser fiber inside 
the ring channel of plasma resectoscope in order not to 
damage the channel (Fig. 1).
Step 1 Start stripping-vaporization from both sides of 
the verumontanum
The first thing is to  observe the situation of prostatic 
hyperplasia and bilateral ureteral orifice. If a lobe of the 
prostate protruding into the bladder obviously, we can 
start the surgery no matter we could watch the orifice. 
We begin to strip and vaporize the prostate tissue with 
160-W power from the verumontanum to both sides 
between the 9- and 3-o’clock positions. For large pros-
tates, we need to vaporize some prostatic tissue around 
the verumontanum firstly to make a space for stripped 
prostate tissue in the verumontanum position (Fig.  2: 
Step 1a and Step 1b).
Step 2 Stripping-vaporization of the 12 o’clock direction
As both lateral lobes of the prostate are gradually 
vaporized, the previous urethra turn to be wider than 
before. Meanwhile the gland of 12-o’clock position 
gradually prominent obviously to the below urethra. We 
go on vaporizing the prostatic tissue of 12-o’clock posi-
tion along the prostatic capsule which was in the same 
stripped plane of 9- and 3-o’clock positions toward the 
bladder neck. When vaporizing the prostatic tissue of 
12-o’clock position, we need to rotate sheath in order to 
Table 1 Surgical equipments in Shandong Provincial Hos-
pital
LBO lithium triborate
160 W LBO laser generator (Beijing Realton Laser Technology Co. Ltd. 
China)
Straight Beam LBO Laser fiber (Beijing Realton Laser Technology Co. Ltd. 
China)
26-Fr Sheath of continuous flow plasma kinetic resectoscope (Olympus 
Corp. Japan)
12° Telescope, Ellik evacuator device (Olympus Corp. Japan)
Endoscopic camera and Video tower (Olympus Corp. Japan)
Ureteral stent (Guide the laser fiber into the ring channel of resectoscope)
Extract forceps (Clamp the specimen of prostate tissue)
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achieve direct vaporization with almost vertical angle 
(Fig. 2: Step 2a and Step 2b).
Step 3 Inward and holistically stripping-vaporization of 
the whole prostate
Both lateral lobes of the prostate are retrograde 
stripped to the prostatic capsule and then vaporized from 
the verumontanum to bladder neck. The stripped pros-
tatic tissue will be vaporized with less bleeding for less 
blood supply. During the procedures, the fiber could face 
the vaporized tissue by contact-type without of angle 
(Fig. 2: Step 3).
Step 4 Stripping-vaporization around the bladder neck 
for a circle
Stripping-vaporization around the bladder neck 
should be taken to prevent injury of bilateral ureteral ori-
fice. Gradually we firstly make an incision at 6-, 3- and 
9-o’clock position so that the triangular area of bladder 
and the prostatic department of urethra are in the same 
horizontal plane. Then we can perform stripping and 
vaporization to whole bladder neck ring along the inci-
sion plane of 6-, 3- and 9-o’clock position. For the pros-
tate which are smaller but obstructive symptoms are 
more severe, we will make incision at 5- and 7-o’clock 
position at the same time (Fig. 2: Step 4).
Step 5 Completion of stripping-vaporization and take 
pathological specimens
Then we will dressing the entire urethra so that make 
a spacious and smooth channel. And now we can select 
a location for taking pathology specimens. Specimens or 
blocks of prostate can be taken out with Ellik evacuator, 
or forceps for smaller tissue piece. Finally a catheter will 
be indwelt with balloon water of 40–60 ml. No need of 
postoperative continuous bladder irrigation and catheter 
traction (Fig. 3).
Results
All the 180 patients were identified forming the cohort 
for this study. Table  2 provides a summary of baseline 
characteristics for the patients. The median age was 
70.2 years (range 60.9–79.4). Of all the patients, 56 had a 
history of urinary retention and 44 were taking antiplate-
let and anticoagulant medication.
Perioperative outcomes are reported in Table  3. The 
mean laser working time was 48.3  ±  14.4  min and the 
mean energy applied was 315.2 ± 122.6 kJ. None of the 
patients required postoperative irrigation. The mean 
catheterization time was 1.5  ±  0.8  days and the mean 
postoperative hospital stay time was 2.6 ± 1.0 days. Two 
patients (1.1 %) were diagnosed with prostate cancer by 
postoperative histopathology examination. For operative 
time, laser working time and energy usage, there were 
four values missing due to incomplete data recording. For 
post-operative length of catheterization and post-opera-
tive duration of hospital stay, there were six values miss-
ing for the same reason.
Functional outcomes in terms of IPSS, Qmax, PVR, 
reductions in PSA and prostate size at baseline and 1, 3, 
6, 12  months post-operation, respectively, are shown in 
Table  4. The data clearly demonstrate that IPSS, Qmax 
and PVR were dramatically improved at 1, 3, 6, and 
12 months after PRSVP (p < 0.01). Compared with pre-
operative values, mean prostate volume and serum PSA 
fell by 63.0 and 60.4  %, respectively, at 1 month after 
PRSVP.
Adverse events are shown in Table  5. Complications 
were categorized as intraoperative, early (<30  days), 
or late (>30  days) postoperative complications. 
Fig. 1 a The 26-Fr Sheath of continuous flow plasma kinetic resecto-
scope for PRSVP. b The user interface of 160-W LBO laser generator. c 
Using the ureteral stent for directing the laser fiber inside the channel. 
d Hand manipulation for the PRSVP
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Complications were few. None of the patients required 
blood transfusion. Capsular perforation was found in 
four patients during PRSVP for both the patients had 
small prostate volume less than 30 ml, and two patients 
experienced bleeding from prostatic venous sinus. Nei-
ther bladder wall nor ureteral orifice was injured in the 
patients. Urinary tract infections with signs of bacteremia 
were seen in nine patients within 1 month of PRSVP. Four 
patients experienced bladder neck contracture undergo-
ing bladder neck incision at 6 months after operation and 
has subsequently done well. No dysuria and secondary 
haemorrhage was observed during the follow-up period. 
Fig. 2 Procedures of the PRSVP. Step 1a Stripping the prostate tissue to the prostatic capsula from the verumontanumon to both sides between 
the 9- and 3-o’clock positions. Step 1b Vaporizing the stripped prostate tissue between the 9- and 3-o’clock positions. Step 2a Stripping the 
prostate tissue of the 12 o’clock direction to the prostatic capsula. Step 2b Vaporizing the stripped prostate tissue of the 12 o’clock direction. Step 3 
Inward and holistically stripping-vaporization of the whole prostate. Step 4 Stripping-vaporization around the bladder neck for a circle
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Fig. 3 a Showing the straight beam working type of green laser. b Stripping the prostate tissue. c Showing the prostatic capsula. d Taking pathol-
ogy specimens during the operation. e Pathological picture shows the prostate hyperplasia (HE staining ×10). f Prostate MRI image after surgery
Table 2 Baseline patient characteristics
Results are reported as mean ± standard deviation (range)
TRUS transrectal ultrasound, PSA prostate-specific antigen, Qmax maximum flow 
rate, IPSS International Prostate Symptom Score, PVR post-void residual urine
Parameter Value
Age (years) 70.2 ± 9.3 (60.9–79.4)
TRUS prostate volume (ml) 66.5 ± 35.3 (32.3–100.8)
PSA (ng/ml) 4.8 ± 2.2 (2.6–6.9)
Qmax (ml/s) 6.5 ± 5.4 (4.3–10.6)
IPSS 24.5 ± 5.2 (19.3–29.6)
PVR (ml) 167.5 ± 158.9 (132.6–203.3)
Patients [n (%)]
 Anticoagulant medication 44 (24.4 %)
 Urinary retention requiring catheterization 56 (31.1 %)
 Prostate biopsy before surgery 50 (27.8 %)
Table 3 Perioperative outcomes
Results are reported as mean ± standard deviation (range)
Mean ± SD Range
Operative time (min) 62.2 ± 16.5 45.8–77.9
Laser working time (min) 48.3 ± 14.4 35.2–62.2
Applied energy (kJ) 315.2 ± 122.6 193.6–433.1
Serum sodium (mmol/l)
 Preoperative 136.5 ± 3.2 133.4–139.6
 Postoperative 134.5 ± 2.8 131.9–137.2
 p value 0.548
Hemoglobin (g/dl)
 Preoperative 13.5 ± 1.7 11.8–15.0
 Postoperative 13.2 ± 1.5 11.7–14.6
 p value 0.534
Catheterization time (day) 1.5 ± 0.8 0.7–2.2
Postoperative hospital stay time (day) 2.6 ± 1.0 1.6–3.5
Page 6 of 8Li et al. SpringerPlus  (2016) 5:308 
Urethral stricture was diagnosed in four patients, who 
were treated by dilatation. None of the patients required 
reoperation because of regrowth of prostate.
Discussion
Currently, TURP is still the gold standard in the surgical 
treatment of BOO caused by BPH. The rapid develop-
ment of laser technology makes PVP be widely recog-
nized (Bach et al. 2012). Three clinical randomized trials 
have demonstrated that PVP at least have equally efficacy 
and safety compared with TURP, especially for the elderly 
and high-risk patients with oral anticoagulation and 
bleeding tendency (Chen et  al. 2012; James et  al. 2015; 
Teng et al. 2013).
Until now, there has been little experience reported on 
the performance of the straight beam green laser vapore-
section in the treatment of BPH (Gong et al. 2014). The 
GOLIATH study carried out by James A. Thomas et  al. 
show that green light laser vaporization with 180 W XPS 
system is safe and effective as TURP for BPO, accord-
ing to 2-year follow-up data (James et  al. 2015). Even 
so, the confirmed shortcomings of PVP include slower 
vaporization speed, uncontrollable bleeding during oper-
ation, poor visibility and recurrence of residual gland 
postoperative (Spaliviero et al. 2008). In terms of the sur-
gical instruments and operating procedures, some con-
ventional methods, such as vaporizing the prostate lobe 
by lobe and vaporization-resection of prostate tissue, 
have been widely reported (Netsch and Bach 2015). Mis-
rai et al. have raised up the “En Bloc” enucleation of the 
prostate using a surgical 532-nm laser (GreenLEP) tech-
nique, which need a morcellator for morcellation of pros-
tate tissue (Misrai et al. 2015). However, the ideal surgical 
approach has not yet appeared.
On the basis of operational experience of PVP over 
10 years, we not only improve the assembly of operation 
instrument scientifically by making full use of the exist-
ing  equipment available, but also put forward our own 
surgical technology of retrograde stripping-vaporization 
using straight beam green laser. We analyzed the statisti-
cal data and achieved good results.
Following aspects are the main innovations and 
research findings: (1) Switching to plasma kinetic resec-
toscope in place of traditional sheath in the PRSVP to 
improve the effect of flushing water. It will increase water 
flow of bladder irrigation during operation. In addition, 
we also developed the method of putting the LBO laser 
fiber into the resectoscope sheath. (2) Improvement of 
vaporization method with straight beam LBO laser fiber. 
During the operation, we perform stripping-vaporizing 
the prostatic tissue by the way of stripping simultane-
ously vaporization. We use contact type vaporization 
during the operation. When there is a bleeder, using the 
laser fiber tip to vaporize the bleeder directly and lowing 
down the power to about 30–60 W can stop the bleeding. 
(3) Traditional PVP operation cannot acquire pathologi-
cal specimen (Malek et  al. 2005). The improved PRSVP 
can obtain pathological specimens from the surgical cap-
sule of prostate to avoid the omission of prostate cancer.
For large prostates, especially in those larger than 
100 g, there is no need to strip the tissue directly reach-
ing the surgical capsule at the beginning of the operation 
(Kim et  al. 2015). Firstly, we usually vaporize the tissue 
Table 4 Preoperative and postoperative functional parameters
Results are reported as mean ± standard deviation
IPSS International Prostate Symptom Score, Qmax maximum flow rate, PVR post-void residual urine, PSA prostate-specific antigen, PV prostate volume
* Highly significant difference compared to baseline, p < 0.005
Parameter Baseline 1 Month 3 Months 6 Months 12 Months
IPSS 24.5 ± 5.2 7.5 ± 2.8* 6.2 ± 2.6* 7.0 ± 2.3* 6.5 ± 2.1*
Qmax (ml/s) 6.5 ± 5.4 19.5 ± 8.2* 20.6 ± 7.1* 22.4 ± 5.4* 21.3 ± 3.8*
PVR (ml) 167.5 ± 158.9 30.2 ± 28.5* 26.2 ± 17.6* 20.5 ± 14.3* 16.8 ± 11.0*
PSA (ng/ml) 4.8 ± 2.2 1.9 ± 1.7* 1.4 ± 1.5* 1.5 ± 1.2* 1.7 ± 1.6*
PV (ml) 66.5 ± 35.3 24.6 ± 10.5* 22.9 ± 8.1* 23.7 ± 9.2* 25.4 ± 9.5*
Table 5 Intraoperative, early, and late postoperative com-
plications classified by Clavien–Dindo grade
Complication Grade Number 
of cases (%)
Intraoperative complications
Capsule perforation 3b 4 (2.2 %)
Bleeding from prostatic venous sinus 1 2 (1.1 %)
Ureteric Orifice injury 2 2 (1.1 %)
Blood transfusion 1 0 (0.0 %)
Early, and late postoperative complications
Transient urinary retention 1 6 (3.3 %)
Urinary tract infection 2 9 (5.0 %)
Bladder neck contracture 3a 4 (2.2 %)
Secondary haemorrhage 1 2 (1.1 %)
Urethral stricture 2 4 (2.2 %)
Reoperation 3a 0 (0.0 %)
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around the verumontanum to achieve a space for the 
next further stripping to capsule.
In patients with small prostates, we can directly strip 
the prostate to the surgical capsule. Actually we have 
been vaporizing a wall of prostate tissue and will create 
a more spacious urethra during the operation. So there 
is obvious superiority by stripping-vaporizing than single 
enucleation which will narrow operation space (Raison 
and Challacombe 2015).
In this study, the perioperative data show that there 
is small fiber power loss, high vaporization efficiency 
and short operative time in the PRSVP. In comparing 
our operative time to the previous study by Gong YG 
and James A, we have experienced slightly longer oper-
ating time, perhaps because the prostate volume was 
larger in our study (Gong et al. 2014; James et al. 2015). 
The follow-up results strongly suggest that the effect of 
PRSVP is lasting. IPSS score decrease continuously; 
Qmax and PVR improve continuously as well. The pros-
tate volume has no recurrence of hyperplasia even reop-
eration required over 1 year of follow-up. The data show 
that the direct clinical effect of PRSVP can be stable and 
sustainable, even further more improvement during the 
follow-up.
In terms of surgical complications, intraoperative blood 
loss is less in patients without blood transfusions, espe-
cially for the patients with oral anticoagulant therapy. The 
surgery has so exact security in blood loss that the cath-
eter time and postoperative time of hospital stay are all 
significantly reduced. The patients with oral anticoagula-
tion do not need to discontinue the anticoagulant drug, 
and there is no significant risk of secondary hemorrhage.
The capsule perforation usually require surgical, endo-
scopic, or radiologic intervention, so it is Clavien 3b. 
There were four patients (2.2  %) who had capsule per-
foration in our study, which is less common with those 
described following TURP (compare with 4 % incidence 
with TURP) and consistent with PVP using the 180- or 
120-W LBO lasers (Mandal et  al. 2013; Rieken et  al. 
2010; Campbell et  al. 2013). We performed a conserva-
tive treatment by the pulling of the catheter without 
re-operated.
Bladder cramps is one of common complications after 
surgery. There are many factors that can cause blad-
der cramps, rinses inappropriate temperature is one of 
the main reasons. In this study, all the patients did not 
use bladder irrigation after the operation, so the bladder 
spasm is rare.
The procedure does not increase the risk of urethral 
stricture and bladder neck contracture. There are four 
cases of bladder neck contracture. All of the four patients 
have a small volume of prostate. This complication asso-
ciated with minor volume of prostate and incision of the 
bladder neck tissue. In this study, the incidence of blad-
der neck sclerosis and urethral stricture are compara-
ble to those previously reported in studies on PVP and 
of low incidence (Rieken et  al. 2010). Urethral stricture 
may due to a plasma resectoscope sheath (26F) is used, 
which has larger diameter than traditional PVP sheath. 
The bladder neck sclerosis and urethral stricture were all 
mild and short like thin membrane and dialatation man-
agement was enough without a bladder neck incision or 
urethrotomy.
The rate of minor complications is similar with previ-
ous literature reports (Gong et al. 2014; Chen et al. 2012). 
The surgical approach does not increase the occurrence 
of injury to the external urethral sphincter which could 
result in real incontinence. There is no case of damage to 
the bilateral ureteral orifices.
Limitation of the study
The main limitations were a short follow-up period and 
the absence of a comparison arm. However, considering 
that we focus on a new surgical approach and provide 
an early experience, 12  months follow-up seems to be 
acceptable. Besides, the effect of PRSVP on sexual func-
tion remain to be explored. Further data from either large 
prospective trials or long-term follow-up is required.
Conclusion
Based on our researches and practices, the 160-W 
straight beam LBO laser PRSVP is effective as a treat-
ment option for symptomatic BPH. This technology 
could offer the possibility of more rapid tissue vaporiza-
tion. Further substantiation of these results by data from 
either large prospective trials or long-term follow-up is 
required.
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